SONOMA PHARMACEUTICALS, INC. (SNOA) Operating cash flow 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.9MFY2026 · since FY2017: -$8.2M → -$3.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$3.9M | -4369.3% |
| FY2025 | -$88,000 | +96.3% |
| FY2024 | -$2.4M | +61.0% |
| FY2023 | -$6.2M | -44.8% |
| FY2022 | -$4.2M | -25.8% |
| FY2021 | -$3.4M | +26.4% |
| FY2020 | -$4.6M | +60.8% |
| FY2019 | -$11.7M | +5.8% |
| FY2018 | -$12.4M | -52.3% |
| FY2017 | -$8.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SNOA financial trends
SNOA RevenueSNOA Net incomeSNOA Net marginSNOA Gross profitSNOA Gross marginSNOA Operating incomeSNOA Operating marginSNOA Free cash flowSNOA Capital expendituresSNOA Return on equitySNOA Stock buybacksSNOA Dividends paidSNOA Total assetsSNOA Total liabilitiesSNOA Shareholders’ equitySNOA overview →